Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | PNP | P00491 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28335557 | 0.91 | ALDH1A1 (0.44) | ALDH1A1PNP | |
| SCHEMBL28333212 | 0.88 | ALDH1A1 (0.42) | ALDH1A1PNP | |
| SCHEMBL389888 | 0.87 | PNP (0.46) | ALDH1A1PNP | |
| SCHEMBL29112126 | 0.72 | ALDH1A1 (0.50) | ALDH1A1HSD17B10 | |
| SCHEMBL6680764 | 0.72 | HPRT1 (0.38) | ALDH1A1PNPHSD17B10 | |
| SCHEMBL27952597 | 0.71 | PNP (0.41) | PNP | |
| SCHEMBL15290224 | 0.71 | ALDH1A1 (0.56) | ALDH1A1PNPTSHRCYP2C19HSD17B10 | |
| SCHEMBL27277482 | 0.68 | ALDH1A1 (0.52) | ALDH1A1PNPTSHRCYP2C19HSD17B10 | |
| SCHEMBL7958461 | 0.68 | ALDH1A1 (0.52) | ALDH1A1TSHRCYP2C19HSD17B10 | |
| SCHEMBL9845196 | 0.66 | ALDH1A1 (0.50) | ALDH1A1PNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12460229-B2 | Recombinant arterivirus replicon systems and uses thereof | Janssen Pharmaceuticals, Inc. (US) | 2025-11-04 | — | — | US | disclosed |
| CN-110352247-B | Compositions and methods for enhancing gene expression | 杨森制药公司 | 2024-06-28 | — | — | CN | disclosed |
| US-20240209379-A1 | COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION | Janssen Pharmaceuticals, Inc. | 2024-06-27 | — | — | US | disclosed |
| EP-3548625-B1 | COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION | JANSSEN PHARMACEUTICALS INC (US) | 2024-06-26 | — | — | EP | disclosed |
| US-11845939-B2 | Compositions and methods for enhancing gene expression | Janssen Pharmaceuticals, Inc. (US) | 2023-12-19 | — | — | US | disclosed |
| US-20230227850-A1 | RECOMBINANT ARTERIVIRUS REPLICON SYSTEMS AND USES THEREOF | Janssen Pharmaceuticals, Inc. | 2023-07-20 | — | — | US | disclosed |
| US-11555205-B2 | Recombinant arterivirus replicon systems and uses thereof | Janssen Pharmaceuticals, Inc. (US) | 2023-01-17 | — | — | US | disclosed |
| US-11219895-B2 | Blood analysis cartridge | KING ABDULAZIZ UNIVERSITY (SA) | 2022-01-11 | — | — | US | disclosed |
| US-20210308674-A1 | BLOOD ANALYSIS CARTRIDGE | KING ABDULAZIZ UNIVERSITY (SA) | 2021-10-07 | — | — | US | disclosed |
| US-20210001333-A1 | MICROFLUIDIC DEVICE FOR MEASURING THE ENZYMATIC ACTIVITY OF THIOPURIN S-METHYLTRANSFERASE | KING ABDULAZIZ UNIVERSITY (SA) | 2021-01-07 | — | — | US | disclosed |
| WO-1996021007-A2 | BACTERIOPHAGE-MEDIATED GENE TRANSFER SYSTEMS CAPABLE OF TRANSFECTING EUKARYOTIC CELLS | CHIRON VIAGENE, INC. (US) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996021036-A2 | NUCLEIC ACID CONDENSING AGENTS WITH REDUCED IMMUNOGENICITY | CHIRON VIAGENE, INC. (US) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996020732-A2 | NON-TRAUMATIC ADMINISTRATION OF GENE DELIVERY VEHICLES | CHIRON CORPORATION (US) | 1996-07-11 | — | — | WO | disclosed |
| EP-0716148-A2 | Recombinant alphavirus vectors | CHIRON VIAGENE, INC. (US) | 1996-06-12 | — | — | EP | disclosed |
| WO-1996017072-A2 | RECOMBINANT ALPHAVIRUS VECTORS | CHIRON VIAGENE, INC. (US) | 1996-06-06 | — | — | WO | disclosed |
| EP-0711829-A2 | Recombinant alphavirus vectors | CHIRON VIAGENE, INC. (US) | 1996-05-15 | — | — | EP | disclosed |
| EP-0694070-A1 | RECOMBINANT ALPHAVIRUS VECTORS | CHIRON CORPORATION (US) | 1996-01-31 | — | — | EP | disclosed |
| WO-1995024928-A2 | HEPARIN-BINDING GROWTH FACTORS FOR GENE THERAPY AND ANTERIOR EYE DISORDERS | PRIZM PHARMACEUTICALS, INC. (US) | 1995-09-21 | — | — | WO | disclosed |
| WO-1995014091-A2 | COMPOSITIONS AND METHODS FOR UTILIZING CONDITIONALLY LETHAL GENES | CHIRON VIAGENE, INC. (US) | 1995-05-26 | — | — | WO | disclosed |
| WO-1995007994-A2 | RECOMBINANT ALPHAVIRUS VECTORS | VIAGENE, INC. (US) | 1995-03-23 | — | — | WO | disclosed |